Picture of Altamira Therapeutics logo

CYTOF — Altamira Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Auris Medical Says Launch Of Am-301 Expected In Selected Markets Towards End Of Q2 2021

March 31 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL PROVIDES BUSINESS UPDATE AND REPORTS SECOND
HALF
AND FULL YEAR 2020 FINANCIAL RESULTS
    * AURIS MEDICAL HOLDING LTD - LAUNCH OF AM-301 EXPECTED IN
SELECTED MARKETS TOWARDS END OF Q2 2021
    * AURIS MEDICAL HOLDING LTD - PHASE 2 TRIAL WITH AM-125 IN
ACUTE
VERTIGO EXPECTED TO COMPLETE ENROLLMENT IN Q3 2021

Source text for Eikon:  ID:nGNX14dNQY 
Further company coverage:  EARS.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Altamira Therapeutics

See all news